TSW
CDNA icon

Thompson Siegel & Walmsley’s CareDx CDNA Stock Holding History

Thompson Siegel & Walmsley’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,745
Closed -$66K – 665
2020
Q3 		$66K Hold
1,745
– – ﹤0.01% 401
2020
Q2 		$62K Sell
1,745
-334
-16% -$9.51K ﹤0.01% 411
2020
Q1 		$45K Buy
+2,079
New +$46.6K ﹤0.01% 414

Other funds holding CDNA

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Thompson Siegel & Walmsley's CDNA Position: Q4 2020 in Review

Thompson Siegel & Walmsley sold out of CareDx (CDNA) in Q4 2020, closing a stake of 1,745 shares — an estimated $66K sold.

Thompson Siegel & Walmsley first reported a position in CDNA in Q1 2020 and held it in 3 quarters. The position peaked at $66K in Q3 2020. 232 funds tracked by Wall St. Rank hold CDNA as of Q4 2020.

  • Thompson Siegel & Walmsley reported no remaining CareDx position as of Q4 2020 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 1,745 CareDx shares in Q4 2020, an estimated $66K.
  • Thompson Siegel & Walmsley first reported a position in CareDx in Q1 2020 and held it in 3 quarters.
  • Thompson Siegel & Walmsley's CareDx position peaked at $66K in Q3 2020.
  • 232 funds tracked by Wall St. Rank held CareDx as of Q4 2020.

Based on Thompson Siegel & Walmsley's 13F filing for Q4 2020, filed 8 Feb 2021.